Electrocardiographic safety profile and monitoring guidelines in pediatric psychopharmacology

被引:0
|
作者
J. Blair
B. Taggart
A. Martin
机构
[1] Yale University School of Medicine,
[2] Yale University School of Medicine,undefined
[3] Child Study Center,undefined
[4] Yale University School of Medicine,undefined
来源
关键词
Keywords: Psychotropics, children, adolescents, electrocardiogram, QTc;
D O I
暂无
中图分类号
学科分类号
摘要
A number of medications commonly used in pediatric psychopharmacology can prolong the QTc interval of the electrocardiogram. QTc prolongation can in turn predispose to torsades de pointes, a sometimes deadly arrhythmia. These considerations are clinically relevant given documented, if still controversial, reports of sudden deaths associated with the use of the tricyclic antidepressant (TCA) desipramine in children. While most reports of QTc prolongation have involved adult patients, this adverse effect can occur in children. After discussing the QTc parameter’s derivation, accuracy, and limitations, this article reviews current knowledge about the propensity of the antipsychotics (both atypical and traditional), TCAs, and alpha agonists to prolong the QTc interval in young patients. Based on the literature reviewed, guidelines are provided for clinical and electrocardiographic monitoring in pediatric psychopharmacology.
引用
收藏
页码:791 / 815
页数:24
相关论文
共 50 条
  • [1] Electrocardiographic safety profile and monitoring guidelines in pediatric psychopharmacology
    Blair, J
    Taggart, B
    Martin, A
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2004, 111 (07) : 791 - 815
  • [2] Assessment of safety in pediatric psychopharmacology - Introduction
    Greenhill, LL
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2003, 42 (06): : 625 - 626
  • [3] Safety Methodology in Pediatric Psychopharmacology Trials
    Yuill, Kathryn
    Carandang, Carlo
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2013, 23 (03) : 148 - 162
  • [4] Safety considerations in the psychopharmacology of pediatric bipolar disorder
    Sun, Amanda Y.
    Woods, Steven
    Findling, Robert L.
    Stepanova, Ekaterina
    [J]. EXPERT OPINION ON DRUG SAFETY, 2019, 18 (09) : 777 - 794
  • [5] Oral azathioprine for the treatment of childhood eczema: safety profile and guidelines for monitoring
    Fuggle, N.
    Bragoli, W.
    Mahto, A.
    Syed, S.
    Roberts, N.
    Martinez, A.
    Harper, J. I.
    Lomas, D.
    Glover, M.
    Kinsler, V.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 : 113 - 114
  • [6] CONTINUOUS ELECTROCARDIOGRAPHIC MONITORING IN PEDIATRIC PRACTICE
    DELTORSO, S
    SOUTHALL, DP
    SHINEBOURNE, EA
    PELLEGRINO, PA
    [J]. RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1981, 7 (04): : 490 - 490
  • [7] Approaches to standardizing safety data collection in pediatric psychopharmacology
    Greenhill, LL
    Fisher, P
    Mosholder, A
    Heiligenstein, J
    Vitiello, B
    [J]. BIOLOGICAL PSYCHIATRY, 2002, 51 (08) : 148S - 148S
  • [8] Review of safety assessment methods used in pediatric psychopharmacology
    Greenhill, LL
    Vitiello, B
    Riddle, MA
    Fisher, P
    Shockey, E
    March, JS
    Levine, J
    Fried, J
    Abikoff, H
    Zito, JM
    McCracken, JT
    Findling, RL
    Robinson, J
    Cooper, TB
    Davies, M
    Varipatis, E
    Labellarte, MJ
    Scahill, L
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2003, 42 (06): : 627 - 633
  • [9] Interim analysis of the START study - extensive electrocardiographic monitoring confirms the good cardiac safety profile of fingolimod
    Limmroth, V.
    Haverkamp, W.
    Dechend, R.
    Lang, M.
    Haas, J.
    Wagner, B.
    Richter, S.
    Schieb, H.
    Ziemssen, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 698 - 698
  • [10] Pediatric Psychopharmacology
    Nazeer, Ahsan
    [J]. PSYCHIATRIC ANNALS, 2021, 51 (10) : 447 - 448